RecruitingNot Applicable

A Hybrid Effectiveness-implementation Evaluation on Programs Promoting Healthy Aging With Sport Exercise (PHASE Program)

Hong Kong1,940 participantsStarted 2023-09-01

Plain-language summary

The goal of this clinical trial is to provide scientific evaluation on the effects of Promoting Healthy Aging with Sport Exercise (PHASE) Programs on the functional capacity of older. Based on the participants' mental well-being and physical health status, they will be provided with several tailored exercise intervention, including 1) football training; 2) gero-technology enhanced multi-component exercise; 3) slow sports and exercise; 4) walking exercise; 5) home-based exercise. A control group is also recruited and provided with no exercise intervention.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age above 60 years Exclusion Criteria: * Any contraindication to exercise training

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Health status self-rated score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Mobility limitation score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention.

Activity level

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Functional mobility score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Sarcopenia risk score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Hand grip strength

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Loneliness score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Trial details

NCT IDNCT06090253

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-08-31

Contact for this trial

Doris Sau Fung YU, PhD

852 3817 6319 dyu1@hku.hk

View on ClinicalTrials.gov More Ageing Well trials

Plain-language summary

What they're measuring

Health status self-rated score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Mobility limitation score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention.

Activity level

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Functional mobility score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Sarcopenia risk score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Hand grip strength

Timeframe: Changes from baseline to 3 month and 6 month post-intervention

Loneliness score

Timeframe: Changes from baseline to 3 month and 6 month post-intervention